Revelation Biosciences Expands Acute Kidney Injury Advisory Board

SAN DIEGO, CA / ACCESS Newswire / June 1, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to treat acute and chronic disease, today announced the expansion of its Acute Kidney Injury (AKI) Advisory Board, with the addition of two new members, Dr. Peter Pickkers and Dr. Lui Forni, ahead of its upcoming Phase 2/3 clinical trial. The distinguished panel comprises internationally recognized nephrologists and critical care physicians who will guide the company's clinical strategy, monitor trial progress, and advance Gemini as a treatment for AKI. Drawing on their collective expertise, the board will help shape the most effective study design to address the significant unmet medical need in AKI and ultimately improve patient outcomes.

Peter Pickkers, MD, PhD

Dr. Pickkers is an internist-intensivist and professor of Experimental Intensive Care Medicine. His research focuses on (pharmacological) modulation of the innate immune response, sepsis, and organ dysfunction, especially the kidney. Dr. Pickkers is Professor of Intensive Care Medicine at the Radboud University Medical Center Nijmegen, the Netherlands. He qualified as MD (1991) and completed his residency in Internal and Intensive Care Medicine at the Radboud University Nijmegen. In 2000 he received his doctorate, titled ‘Vascular effects of diuretics', cum laude. His research focuses on pharmacological modulation of the innate immune response in translational models and patients, and the consequences for organ function, with a focus on the kidney and brain. Up to now, 28 PhD's were completed under his supervision. With over 2000 endotoxemia experiments performed, he leads the most active group using this human in vivo model of inflammation worldwide. He has given invited lectures on all major meetings in the field of intensive care medicine and nephrology, and he cooperates with various international experts in the field of sepsis and nephrology and has participated in several guideline and steering committees. Dr. Pickkers is also on the editorial board of Intensive Care Medicine, Intensive Care Medicine Experimental and Shock.

Schreibe Deinen Kommentar